Controlled infection with a therapeutic virus defines the activation kinetics of human natural killer cells in vivo.
El-Sherbiny YM, Holmes TD, Wetherill LF, Black EV, Wilson EB, Phillips SL, Scott GB, Adair RA, Dave R, Scott KJ, Morgan RS, Coffey M, Toogood GJ, Melcher AA, Cook GP.
El-Sherbiny YM, et al. Among authors: cook gp.
Clin Exp Immunol. 2015 Apr;180(1):98-107. doi: 10.1111/cei.12562.
Clin Exp Immunol. 2015.
PMID: 25469725
Free PMC article.
Clinical Trial.